Cargando…
Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947781/ https://www.ncbi.nlm.nih.gov/pubmed/35339221 http://dx.doi.org/10.1016/S0140-6736(22)00178-7 |
| _version_ | 1784674521172672512 |
|---|---|
| author | Krause, Philip R Rees, Helen Figueroa, J Peter Swaminathan, Soumya Restrepo, Ana Maria Henao |
| author_facet | Krause, Philip R Rees, Helen Figueroa, J Peter Swaminathan, Soumya Restrepo, Ana Maria Henao |
| author_sort | Krause, Philip R |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8947781 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89477812022-03-25 Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply Krause, Philip R Rees, Helen Figueroa, J Peter Swaminathan, Soumya Restrepo, Ana Maria Henao Lancet Correspondence Elsevier Ltd. 2022 2022-03-24 /pmc/articles/PMC8947781/ /pubmed/35339221 http://dx.doi.org/10.1016/S0140-6736(22)00178-7 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Krause, Philip R Rees, Helen Figueroa, J Peter Swaminathan, Soumya Restrepo, Ana Maria Henao Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply |
| title | Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply |
| title_full | Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply |
| title_fullStr | Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply |
| title_full_unstemmed | Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply |
| title_short | Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply |
| title_sort | booster vaccines for covid-19 vaccine breakthrough cases? – authors' reply |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947781/ https://www.ncbi.nlm.nih.gov/pubmed/35339221 http://dx.doi.org/10.1016/S0140-6736(22)00178-7 |
| work_keys_str_mv | AT krausephilipr boostervaccinesforcovid19vaccinebreakthroughcasesauthorsreply AT reeshelen boostervaccinesforcovid19vaccinebreakthroughcasesauthorsreply AT figueroajpeter boostervaccinesforcovid19vaccinebreakthroughcasesauthorsreply AT swaminathansoumya boostervaccinesforcovid19vaccinebreakthroughcasesauthorsreply AT restrepoanamariahenao boostervaccinesforcovid19vaccinebreakthroughcasesauthorsreply |